Clik here to view.
FDA clears Allergan’s Xen gel stent for glaucoma
Allergan (NYSE:AGN) said today that it won FDA approval for its Xen gel stent and injector for glaucoma. The federal watchdog indicated the drug device for the management of refractory glaucoma, in...
View ArticleClik here to view.
Mylan declines to testify at Senate committee hearing
Mylan (NDSQ:MYL) declined to testify at a U.S. Senate committee regarding its $465 million pending settlement to deal with charges that it underpaid government healthcare programs when it...
View ArticleClik here to view.
Corvia Medical touts 1-year data for InterAtrial shunt
Corvia Medical today released 1-year results from the Reduce LAP-HF clinical trial of its InterAtrial shunt device, touting a good safety profile and sustained device performance. Results from the...
View ArticleClik here to view.
Hill-Rom enters home monitoring arena with Welch Allyn hypertension program
Hill-Rom (NYSE:HRC) said today it is entering the home monitoring field as its subsidiary Welch Allyn launches its Home Hypertension program. The program will allow patients to monitor their health at...
View ArticleClik here to view.
Skyline Medical wins Health Canada nod for Streamway medical fluid disposal...
Skyline Medical said today it won Health Canada approval for its Streamway medical fluid disposal device, launching it and its associated accessories in the region. The Streamway System is an automated...
View ArticleClik here to view.
Topical immunotherapy combo effective against early skin cancer
Researchers from the Washington University School of Medicine and Harvard Medical School have shown that a combination of 2 topical drugs can trigger an immune response against precancerous skin...
View ArticleClik here to view.
SentreHeart recalls FindrWIRZ Guidewire System over coating separation issues
SentreHeart is recalling a select number of its FindWIRZ guidewire systems over PTFE coating separation issues, according to an FDA release posted today. The recall has been given a Class I label from...
View ArticleClik here to view.
Propel Orthodontics ratchets up patent spat with OrthoAccel Technologies
Propel Orthodontics said today that the U.S. Patent and Trademark Office’s Patent Trial and Appeals Board accepted a petition for an Inter Partes review of a patent spat between it and rival OrthoAccel...
View ArticleClik here to view.
Appeals court reverses Cochlear win in Advanced Bionics patent spat
A federal appeals court last week overturned a win for Cochlear Ltd. (ASX:COH) in its patent spat with Advanced Bionics over hearing implant technology, sending the case back to district court for...
View ArticleClik here to view.
MassDevice.com +5 | The top 5 medtech stories for November 22, 2016
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s...
View ArticleClik here to view.
Baxter touts blood purification efficiency in EBP studies
Baxter (NYSE:BAX) today released data from 2 studies on extracorporeal blood purification studies, touting the blood purification method’s ability to remove harmful molecules linked to inflammation....
View ArticleClik here to view.
French biomed incubator Clinatec raises €10m
French biomedical research center Clinatec said today that it has raised $10.6 million (€10 million) to support research for diagnosis and treatment of neurodegenerative diseases, cancer and motor...
View ArticleClik here to view.
Immunovaccine’s targeted ovarian cancer therapy wins orphan drug status in EU
Immunovaccine Inc. said today that the European Medicines Agency granted orphan drug designation for its immunotherapy candidate for ovarian cancer in the E.U. Orphan drug designation is granted to...
View ArticleClik here to view.
Helius Medical extends U.S. Army contract, looks to future of portable neuromod
Helius Medical Technologies said this week it expanded a source cost sharing contract with the U.S. Army Medical Research and Materiel Command, while its CEO Phil Deschamps is looking to the future of...
View ArticleClik here to view.
French Competent Authority provides roadmap for manufacturers as European...
By Stewart Eisenhart, Emergo Group Medical device regulators in France have published new information for manufacturers on how to adjust to an expected decline in Notified Bodies in Europe due to more...
View ArticleClik here to view.
Neovasc dodges investor lawsuit over $70m loss to CardiAQ Valve
Neovasc (NSDQ:NVCN) yesterday dodged an investor lawsuit brought in the wake of its $70 million loss to replacement mitral valve rival and Edwards Lifesciences (NYSE:EW) subsidiary CardiAQ Valve. A...
View ArticleClik here to view.
Allergan expands neurological portfolio with $125m Chase Pharmaceuticals buy
Allergan (NYSE:AGN) said today that it acquired Chase Pharmaceuticals for an upfront payment of $125 million, expanding the Dublin-based company’s neurological portfolio. Washington, D.C.-based Chase...
View ArticleClik here to view.
Supersonic spray produces nanomaterials for wearable electronics
Researchers from the University of Illinois at Chicago and Korea University have developed an ultrathin, highly conductive nanomaterial produced by a supersonic spray, according to the study published...
View ArticleClik here to view.
Appeals court overturns Stryker’s $9m win over insurer in Duracon Uni-Knee...
A federal appeals court last week overturned a $9 million win for Stryker (NYSE:SYK) over TIG Insurance. Stryker, which acquired the Duracon Uni-Knee with its $1.9 billion buyout of Howmedica from...
View ArticleClik here to view.
Xtant Medical wins FDA nod for Xsert lumbar implant
Xtant Medical (NYSE:XTNT) said today that it won 510(k) clearance from the FDA for its Xsert lumbar expandable interbody spine implant. The device is designed for lumbar fusion at 1 or 2 levels and is...
View Article